- Trials with a EudraCT protocol (28,941)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
28,941 result(s) found for: Informed Consent.
Displaying page 501 of 1,448.
EudraCT Number: 2013-002535-24 | Sponsor Protocol Number: BIOS-13-005 | Start Date*: 2013-09-20 |
Sponsor Name:Ethicon Inc., a Johnson & Johnson Co. | ||
Full Title: A Phase III Randomized, Controlled, Superiority Study Evaluating EVARREST™ Fibrin Sealant Patch Versus Standard of Care Treatment in Controlling Parenchymal Bleeding During Hepatic Surgery | ||
Medical condition: Subjects undergoing elective, open, hepatic surgery during which a resection plane is created and wherein an appropriate Target Bleeding Site is identified | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-003501-25 | Sponsor Protocol Number: ECM2013 | Start Date*: 2014-02-20 | |||||||||||
Sponsor Name:Mesoestetic Pharma group S.L. | |||||||||||||
Full Title: Efficacy and safety of a 4% hydroquinone cream (Melanoderm 4%) for the treatment of melasma: a randomized controlled split-face study. | |||||||||||||
Medical condition: Facial melasma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000478-42 | Sponsor Protocol Number: 008285QM | Start Date*: 2013-02-18 |
Sponsor Name:Queen Mary, University of London | ||
Full Title: NEPTUNE: A Randomised Phase II Study of Neoadjuvant TAK-700 and Leuprorelin Acetate versus Surgery Alone in Intermediate and High Risk Clinically Localized Prostate Cancer | ||
Medical condition: High or Intermediate Risk, Untreated, Clinically Localised Prostate Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-000815-15 | Sponsor Protocol Number: BOS-1168-WEI-0080-I | Start Date*: 2011-08-02 |
Sponsor Name:Medizinische Fakultät der technischen Universität Muenchen | ||
Full Title: BOSTRIP (Investigator Initiated Trial) (Biomarkers of systemic treatment response in Psoriasis) Differential analysis of metabolomic profiles in patients with chronic plaque psoriasis underg... | ||
Medical condition: Psoriasis is a chronic hyperproliferative and inflammatory skin disease with its major subtype, chronic plaque-type psoriasis, affecting approximately 2% of individuals in Western populations. It m... | ||
Disease: | ||
Population Age: Elderly | Gender: | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001419-38 | Sponsor Protocol Number: MM1414 | Start Date*: 2014-07-02 | |||||||||||
Sponsor Name:Center for Cancer Immune Therapy | |||||||||||||
Full Title: T-cell therapy in combination with vemurafenib for BRAF mutated metastatic melanoma | |||||||||||||
Medical condition: Metastatic malignant melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000334-36 | Sponsor Protocol Number: Keplat-HU01 | Start Date*: 2013-05-13 |
Sponsor Name:Sager Pharma Ltd. | ||
Full Title: A randomised, multicentre, open-label, cross-over study to investigate the efficacy and safety of Keplat® and Flector® patch in patients with pain caused by Osteoarthritis of the knee | ||
Medical condition: Pain caused by Osteoarthritis of the knee. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-003154-12 | Sponsor Protocol Number: FSK2011-01 | Start Date*: 2011-11-16 |
Sponsor Name:Privatärztliche urologische Partnerschaft GbR, EuromedClinic | ||
Full Title: Circulating Tumor Cells in Patients with Castration Resistant Metastatic Prostate Cancer Undergoing Zoledronate Therapy | ||
Medical condition: hormone refractory metastatic prostate cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-004860-37 | Sponsor Protocol Number: 280312BS | Start Date*: Information not available in EudraCT |
Sponsor Name:Arcutis Pharmaceuticals | ||
Full Title: A phase IIIb/IV, single-center, randomized, controlled, observer-blind study to assess the effects of topical formulations containing clindamycin-benzoyl peroxide on epidermal functions in subjects... | ||
Medical condition: Healthy volunteer trial to investigate the effects of IDP-110 Gel compared to two marketed products containing cindamycin-benzoyl peroxide on epidermal functions | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-004138-26 | Sponsor Protocol Number: ABAVAS | Start Date*: 2007-11-04 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PARMA | |||||||||||||
Full Title: USE OF ABATACEPT IN ANCA-ASSOCIATED VASCULITIS | |||||||||||||
Medical condition: Patients with ANCA-associated Vasculitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013763-19 | Sponsor Protocol Number: CQAB149BIT01 | Start Date*: 2009-09-24 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: Multicenter, randomized, blinded, placebo controlled, cross over, single dose study to assess the effect of indacaterol (150 �g) versus tiotropium (18 �g) on Inspiratory Capacity in moderate COPD p... | |||||||||||||
Medical condition: moderate COPD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014831-18 | Sponsor Protocol Number: fmd/01 | Start Date*: 2009-09-25 | |||||||||||
Sponsor Name:RUNMC | |||||||||||||
Full Title: Short term statin treatment and endothelial dysfunction due to ischemia and reperfusion injury | |||||||||||||
Medical condition: ischemia and reperfusion injury endothelial dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013791-49 | Sponsor Protocol Number: RHM MED 0879 | Start Date*: 2009-09-23 | |||||||||||
Sponsor Name:Southampton Universities Hospital Trust | |||||||||||||
Full Title: Safety and Efficacy of parenteral KGF in moderate asthma subjects | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006885-27 | Sponsor Protocol Number: ADA-periSPA2008 | Start Date*: 2009-04-21 | |||||||||||
Sponsor Name:Clinical Immunology and Rheumatology | |||||||||||||
Full Title: EFFICACY AND SAFETY OF ADALIMUMAB (HUMIRA®) IN PATIENTS WITH PERIPHERAL SPONDYLOARTHRITIS WITHOUT ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS | |||||||||||||
Medical condition: PERIPHERAL SPONDYLOARTHRITIS WITHOUT ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004650-93 | Sponsor Protocol Number: botuline5 | Start Date*: 2007-10-10 | |||||||||||
Sponsor Name:University Medical Center Groningen | |||||||||||||
Full Title: The effect of Botulinum toxin A injections for overactive bladder on detrusor contractility | |||||||||||||
Medical condition: Neurogenic or idiopathic overactive bladder, not adequately responding to anticholinergic therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001568-35 | Sponsor Protocol Number: RGHT000559 | Start Date*: 2008-06-24 |
Sponsor Name:BELFAST HEALTH & SOCIAL CARE TRUST | ||
Full Title: Comparison of fascia iliac compartment block with conventional sedation to facilitate the positioning of patients with fractured neck of femur for spinal anaesthesia and the effect of nerve blockad... | ||
Medical condition: Investigation of the use a Fascia Iliaca nerve blockade for both positioning for spinal anaesthesia and postoperative analgesia in patients undergoing operative repair of fractured neck of femur. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-014396-43 | Sponsor Protocol Number: HN001 (TEMHEAD) | Start Date*: 2010-02-09 | |||||||||||
Sponsor Name:Medical School Hannover | |||||||||||||
Full Title: A single arm, open-label multicenter phase II trial of temsirolimus in patients with relapsed/ recurrent squamous cell cancer of the Head and Neck (HNSCC) | |||||||||||||
Medical condition: Patients with metastatic or local recurrenct squamous carcinoma of the head and neck (HNSCC) who have measurable progressive disease after platinum-based radiochemotherapy or recurrence or metastat... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-008376-14 | Sponsor Protocol Number: COD_REG_46_DGR _13751_07 | Start Date*: 2009-02-24 | |||||||||||
Sponsor Name:AZIENDA ASL BRESCIA | |||||||||||||
Full Title: A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED TRIAL TO INVESTIGATE EFFICACY AND SAFETY OF COMBINED TREATMENT OF GUGGULU AND TRIPHALA FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND OVERWEIGHT IN SUB... | |||||||||||||
Medical condition: high blood cholesterol overweight | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018852-29 | Sponsor Protocol Number: CRFB002DDE13 | Start Date*: 2010-06-10 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: A 12-month, two-armed, randomized, double-masked, multicenter, Phase IIIb study assessing the efficacy and safety of laser photocoagulation as adjunctive to Ranibizumab intravitreal injections vs. ... | |||||||||||||
Medical condition: diabetic macular edema | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005304-93 | Sponsor Protocol Number: ZOL40/02 | Start Date*: 2009-02-13 | ||||||||||||||||
Sponsor Name:North Bristol Trust | ||||||||||||||||||
Full Title: A Randomised Control Trial To Evaluate Whether Zoledronate Prevents Bone Loss In Acute Exacerbations Of Multiple Sclerosis | ||||||||||||||||||
Medical condition: Bone loss in patients with Multiple Sclerosis (MS) who require large short term doses of methylprednisolone for exacerbations of their disease. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-004541-15 | Sponsor Protocol Number: FRA.LOS.2007 | Start Date*: Information not available in EudraCT |
Sponsor Name:Johann Wolfgang Goethe-Universität Frankfurt am Main | ||
Full Title: A Randomized Controlled Open-Label Phase IV Mono Center Study to Compare the Reponse Profiles of Montelukast versus Fluticason in Children with Preschool Asthma | ||
Medical condition: bronchial asthma is a very common medical problem in 3-7 year old children, often requiring hospitalization and demanding treatment on demand or permanently. Our trial is to compare to established ... | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
